Getty Images
Industryweek 9396 Pharmaceuticals

Big Pharma Takeover Bid Goes to Shareholders

Sept. 8, 2015
Management at Perrigo, manufacturer of over-the-counter medications including Claritin and Sudafed, has refused to engage in merger talks with Mylan. 

NEW YORK—Pharmaceutical company Mylan (IW 500/147) said Tuesday that it would take its offer to buy Perrigo directly to Perrigo shareholders following refusals by the company's management to engage in merger talks.

Mylan, a large generic drugs company, will launch the offer to Perrigo shareholders on Monday and Perrigo shareholders will be eligible to vote until November 13. Perrigo makes over-the-counter medications such as Claritin and Sudafed.

Mylan has proposed $75 in cash and 2.3 Mylan shares for each Perrigo share. Perrigo shareholders would own about 40% of the combined company. Mylan said the transaction values Perrigo at $31.8 billion, based on Mylan's closing share price Friday. 

Mylan initially approached Perrigo in April with a takeover deal that it valued at the time at $35.7 billion, but since then Mylan's shares have fallen.

Perrigo has repeatedly said the Mylan bid "substantially undervalues" the company, reiterating that stance on August 28 after two-thirds of Mylan shareholders voted in favor of the proposed takeover of Perrigo.

Mylan executive chairman Robert Coury said in a letter to Perrigo chief executive Joseph Papa that the outcome now rests with Perrigo shareholders.

"You and your Board are now unable to stop the combination," Coury said.

"At this point Perrigo's management has no role to play in the process, and the only role the Perrigo Board has is to issue its recommendation to Perrigo shareholders."

In mid-morning trade, Perrigo shares rose 1.2% to $180.92, while Mylan shares rose 0.7% to $48.36.

Copyright Agence France-Presse, 2015

Popular Sponsored Recommendations

What Does Agility Look Like for Today's Auto Industry?

Dec. 4, 2023
Without modern technologies, enterprises aren't able to fully analyze the risks and respond to ongoing supply chain issues and semiconductor shortages.

Electric Vehicles Spark New Opportunities in the Automotive Industry

Dec. 4, 2023
Automakers have increased plans to produce Electric Vehicles to meet customer demand for low emissions. With this radical shift, new opportunities and challenges for the auto ...

You Cannot Stay Competitive by Bolting New Technologies to a Legacy ERP

Oct. 20, 2023
Read this white paper to understand the benefits of shifting to a next-generation ERP system as part of a DOP.

Digitally Transforming Data and Processes With Product Lifecycle Management

Oct. 29, 2023
Manufacturers face increasing challenges in product development as they strive to consistently deliver improved results. Discover how industry leaders are improving time-to-market...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!